Investigation of antitumor effects of Lactobacillus crispatus in experimental model of breast cancer in BALB/c mice

Immunotherapy

Volumn 10, Issue 2, 2018, Pages 119-129

  Motevaseli, Elahe ^a   Khorramizadeh, Mohammad Reza ^a,b   Hadjati, Jamshid ^c   Bonab, Samad Farashi ^c   Eslami, Solat ^d   Ghafouri Fard, Soudeh ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

breast cancer; lactobacilli; MDSC; ROS

Indexed keywords

ARGINASE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; LACTIC ACID; PTGS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARGINASE GENE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; COX2 GENE; FEMALE; GENE; GENE EXPRESSION; IMMUNE RESPONSE; INOS GENE; LACTOBACILLUS CRISPATUS; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; SPLEEN; TUMOR VOLUME; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; EXPERIMENTAL MAMMARY NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; HEAT; HUMAN; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOT TEMPERATURE; HUMANS; INJECTIONS, INTRAPERITONEAL; LACTIC ACID; LACTOBACILLUS CRISPATUS; MAMMARY NEOPLASMS, ANIMAL; MICE; MODELS, ANIMAL; MYELOID-DERIVED SUPPRESSOR CELLS; NEOPLASM TRANSPLANTATION; REACTIVE OXYGEN SPECIES; TUMOR BURDEN;

EID: 85039049583     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt-2017-0088     Document Type: Article

References (25)

1. Linnebacher M, Maletzki C, Klier U, Klar E. Bacterial immunotherapy of gastrointestinal tumors. Langenbecks Arch. Surg. 397(4), 557-568 (2012).
2. Memarrast F, Ghafouri-Fard S, Kolivand S et al. Comparative evaluation of probiotics effects on plasma glucose, lipid and insulin levels in streptozotocin-induced diabetic rats. Diabetes Metab. Res. Rev. 33 (7), doi:10.1002/dmrr.2912 (2017) (Epub ahead of print).
3. Abedin-Do A, Taherian-Esfahani Z, Ghafouri-Fard S, Ghafouri-Fard S, Motevaseli E. Immunomodulatory effects of Lactobacillus strains: emphasis on their effects on cancer cells. Immunotherapy 7(12), 1307-1329 (2015).
4. Azam R, Ghafouri-Fard S, Tabrizi M et al. Lactobacillus acidophilus and Lactobacillus crispatus culture supernatants downregulate expression of cancer-Testis genes in the MDA-MB-231 cell line. Asian Pac. J. Cancer Prev. 15(10), 4255-4259 (2014).
5. Esfandiary A, Abedin-DoA, Taherian-Esfahani Z, Ghafouri-Fard S, Motevaseli E. Intact expression of hypoxia-inducible factor 1α (HIF-1α) gene in HeLa cell line following treatment with lactobacilli supernatants. Int. J. Cancer Manag. 10(2), e4774 (2017).
6. Esfandiary A, Taherian-Esfahani Z, Abedin-Do A et al. Lactobacilli modulate hypoxia-inducible factor (HIF)-1 regulatory pathway in triple negative breast cancer cell line. Cell J. 18(2), 237-244 (2016).
7. Motevaseli E, Azam R, Akrami SM et al. The effect of Lactobacillus crispatus and Lactobacillus rhamnosus culture supernatants on expression of autophagy genes and HPV E6 and E7 oncogenes in the HeLa cell line. Cell J. 17(4), 601 (2016).
8. Taherian-Esfahani Z, Abedin-Do A, Nouri Z, Mirfakhraie R, Ghafouri-Fard S, Motevaseli E. Lactobacilli differentially modulate mTOR and Wnt/β-catenin pathways in different cancer cell lines. Iran. J. Cancer Prev. 9(3), e5369 (2016).
9. Chen L, Huang TG, Meseck M, Mandeli J, Fallon J, Woo SLC. Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. Mol. Ther. 15(12), 2194-2202 (2007).
10. Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J. Clin. Immunol. 32(6), 1353-1359 (2012).
11. Aragon F, Carino S, Perdigon G, De Leblanc AD. Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431. J. Immunother. 38(5), 185-196 (2015).
12. Yazdi MH, Mahdavi M, Kheradmand E, Shahverdi AR. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice. Arzneimittel-Forschung 62(11), 525-531 (2012).
13. Hu JT, Wang CF, Ye LP et al. Anti-Tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice. J. Biosciences 40(2), 269-279 (2015).
14. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9(3), 162-174 (2009).
15. Eslami S, Hadjati J, Motevaseli E et al. Lactobacillus crispatus strain SJ-3C-US induces human dendritic cells (DCs) maturation and confers an anti-inflammatory phenotype to DCs. APMIS 124(8), 697-710 (2016).
16. Chen L, Huang T-G, Meseck M, Mandeli J, Fallon J, Woo SL. Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. Mol. Ther. 15(12), 2194-2202 (2007).
17. Corzo CA, Cotter MJ, Cheng PY et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182(9), 5693-5701 (2009).
18. Ghafouri-Fard S, Shamsi R, Seifi-Alan M, Javaheri M, Tabarestani S. Cancer-Testis genes as candidates for immunotherapy in breast cancer. Immunotherapy 6(2), 165-179 (2014).
19. Ghafouri-Fard S, Ghafouri-Fard S. siRNA and cancer immunotherapy. Immunotherapy 4(9), 907-917 (2012).
20. Wesolowski R, Markowitz J, Carson WE, 3rd. Myeloid derived suppressor cells-A new therapeutic target in the treatment of cancer. J. Immunother Cancer 1, 10 (2013).
21. Ghahremanfard F, Alavy Toussy J, Kazeminezhad B, Ramezani F. Role of cyclooxygenese-2 (COX-2) expression in breast cancer differentiation and its relationship with hormone receptors status. Iran. J. Pathol. 8(4), 235-240 (2013).
22. Sharma S, Yang S-C, Zhu L et al. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res. 65(12), 5211-5220 (2005).
23. Howe LR. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res. 9(4), 1 (2007).
24. Bocca C, Ievolella M, Autelli R et al. Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-To-mesenchymal transition and invasiveness. Expert Opin Ther. Targets 18(2), 121-135 (2014).
25. Sun J, Shi YH, Le GW, Ma XY. Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J. Gastroenterol. 11(40), 6330-6337 (2005).